相关实验视频

Updated: Jul 20, 2026

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

两种ALS的核心特征,降低STMN2和致病性TDP-43,协同加速小鼠的运动衰退

Kelsey L Krus¹, Ana Morales Benitez¹, Amy Strickland²

¹Department of Developmental Biology, Washington University School of Medicine, St. Louis 63110, United States.

Experimental neurology

|November 27, 2024

概括

减少的Stathmin2 (Stmn2) 功能加剧了小鼠的TDP-43病理,导致运动缺陷和异常线粒体. 恢复Stmn2可能治疗神经退行性疾病,如ALS.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

病理性TDP-43聚合是肌缩侧面硬化症 (ALS) 和前性痴呆症的核心.
异常拼接的Stathmin2 (Stmn2) mRNA在神经退行性疾病中被发现,其耗尽会导致类似于ALS的症状.
TDP-43 调节了人类的 Stmn2 拼接,但不能调节小鼠的 Stmn2,因此需要新的模型来研究它们的相互作用.

研究的目的:

在小鼠模型中研究降低STMN2功能和TDP-43功能障碍的协同效应.
确定部分STMN2损失是否会加剧TDP-43依赖性病理和神经退行.

主要方法:

产生了一种非功能性Stmn2等位基因和一个突变的TDP-43^Q331K等位基因的跨异构基因小鼠.
评估行为表现型,包括运动缺陷.
在大脑,脊髓,外围神经和神经肌肉结节 (NMJs) 中检查的神经病理学.
在远端轴突和NMJ中分析了线粒体形态.

主要成果:

跨异合体的小鼠表现出早期发作的,渐进的运动缺陷.
在中枢或外周神经系统或NMJs中没有发现显著的神经病理.
在受影响小鼠的远端轴突和NMJ中观察到异常的线粒体形态.
证实了减少的STMN2和突变的TDP-43等位基因之间的协同作用.

结论:

部分STMN2损失显著加剧了TDP-43相关的表型,导致运动缺陷和线粒体异常.
轴突和NMJ中的线粒体功能障碍可能导致观察到的运动缺陷.
在发生广泛退行之前,STMN2恢复为TDP-43蛋白质病变提供了潜在的治疗策略.

关键词:

这就是ALS.这是一个FTD.神经退行发生神经退行.神经病变是一种神经病变.这是STMN2的标志.斯塔特米恩 (Stathmin) 是一个国家.在TARDBP中,TARDBP是TARDBP.在TDP-43中使用.

更多相关视频

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

相关概念视频

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...